Valion Bio reported revenue of $0.04M for the quarter ended Jun 2026, down 44.3% year over year. This income statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||
| Revenue | 0.27M | 0.28M | 0.39M | 0.43M | 0.53M | 0.48M | 0.41M | 0.38M | 0.16M | 0.28M | 0.36M | 0.33M | 0.14M | 0.13M | 0.18M | 0.07M | 0.09M | 0.15M | 0.08M | 0.04M | |
| Cost of RevenueCost of Rev | 0.30M | 0.30M | 0.39M | 0.36M | 0.40M | 0.41M | 0.36M | 0.26M | 0.10M | 0.17M | 0.35M | 0.17M | 0.11M | 0.08M | 0.42M | 0.02M | 0.03M | 0.29M | 0.01M | 0.01M | |
| Gross Profit | -0.03M | -0.03M | -0.00M | 0.07M | 0.12M | 0.06M | 0.04M | 0.11M | 0.06M | 0.11M | 0.01M | 0.17M | 0.03M | 0.04M | -0.24M | 0.05M | 0.05M | -0.14M | 0.07M | -0.04M | |
| Operating items | |||||||||||||||||||||
| Research & DevelopmentR&D | 0.34M | 0.45M | 0.69M | 0.68M | 1.12M | 0.49M | 0.50M | 0.49M | 0.47M | 0.48M | 0.73M | 0.51M | 0.30M | 0.42M | 0.33M | 0.34M | 0.66M | 0.86M | |||
| Selling, General & AdministrativeSG&A | 0.48M | 0.58M | 1.28M | 1.23M | 1.52M | 1.76M | 1.36M | 1.28M | 1.27M | 1.05M | 1.15M | 0.89M | 0.79M | 0.82M | 0.67M | 1.04M | 0.91M | 1.06M | |||
| Other Operating ExpensesOther Opex | 0.19M | 0.17M | 0.31M | 0.40M | 0.50M | 0.40M | 0.43M | 0.46M | 0.45M | 0.34M | 0.36M | 0.26M | 0.21M | 0.24M | 0.18M | 0.43M | -0.12M | ||||
| Operating ExpensesOpex | 1.02M | 1.20M | 2.29M | 2.31M | 3.14M | 2.65M | 2.30M | 2.23M | 2.19M | 1.87M | 2.25M | 1.65M | 1.30M | 1.48M | 1.24M | 1.56M | 1.99M | 2.34M | |||
| Operating IncomeOp. Inc | -1.05M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.27M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| EBIT | -1.05M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.27M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Non-operating items | |||||||||||||||||||||
| Non Operating Interest Expenses | 0.22M | 0.06M | |||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | ||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.16M | 0.08M | -1.79M | -0.00M | |||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.04M | -1.09M | -1.43M | 0.00M | 0.00M | -0.06M | 0.01M | 0.00M | 0.00M | -0.11M | |||||||||||
| Net income details | |||||||||||||||||||||
| EBT | -1.28M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.33M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Profit After TaxPAT | -1.09M | -2.32M | -3.72M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.27M | -1.43M | -1.50M | -1.50M | -1.93M | -2.60M | |||
| Income from Continuing OperationsIncome (Continuing) | -1.28M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.33M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Consolidated Net IncomeConsol Net Inc. | -1.28M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.33M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Income towards Parent CompanyParent Net Inc | -1.28M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.33M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Net Income towards Common StockholdersNet Income | -1.28M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.33M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Additional items | |||||||||||||||||||||
| EPS (Basic) | -13.46 | -11.92 | -16.40 | -5.76 | -7.84 | -667.53 | -582.80 | -262.89 | -179.01 | -36.98 | -70.74 | -25.23 | -8.27 | -5.78 | -129.01 | -63.13 | -54.86 | -46.92 | |||
| EPS (Diluted) | -13.46 | -11.92 | -16.40 | -5.76 | -7.84 | -6.68 | -5.83 | -262.89 | -179.01 | -36.98 | -70.74 | -25.23 | -8.27 | -5.78 | -129.01 | -63.13 | -54.86 | -70.32 | |||
| Shares Outstanding | 0.09M | 0.10M | 0.14M | 0.39M | 0.38M | 0.00M | 0.00M | 0.01M | 0.01M | 0.05M | 0.03M | 0.06M | 0.16M | 0.25M | 0.01M | 0.02M | 0.04M | 0.05M | 0.05M | 0.14M | |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.09M | 0.10M | 0.14M | 0.39M | 0.38M | 0.39M | 0.39M | 0.01M | 0.01M | 0.05M | 0.03M | 0.06M | 0.16M | 0.25M | 0.01M | 0.02M | 0.04M | 0.04M | 0.04M | 0.04M | |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.09M | 0.11M | 0.14M | 0.39M | 0.38M | 0.00M | 0.00M | 0.01M | 0.01M | 0.05M | 0.03M | 0.06M | 0.16M | 0.25M | 0.01M | 0.03M | 0.04M | 0.05M | 0.05M | 0.14M | |
| EBITDA | -1.05M | -1.23M | -2.29M | -2.24M | -3.02M | -2.58M | -2.26M | -2.12M | -2.12M | -1.76M | -2.24M | -1.48M | -1.27M | -1.43M | -1.48M | -1.51M | -1.93M | -2.48M | |||
| Interest ExpensesInt Expense | 0.22M | 0.06M |